← All trials
NCT06249919
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 19, 2024
- Primary completion
- Jun 19, 2025
- Completion date
- Jun 19, 2025
- First posted
- Feb 8, 2024
- Last posted
- Oct 15, 2024
- Enrollment
- 118
- Arms / groups
- 4 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Neuracle Science Co., LTD.Lead sponsor
- Korea UniversityCollaborator
- Yonsei UniversityCollaborator
- Sungkyunkwan UniversityCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.